
October 2007
Printer-friendly version
Eye Research at St. John’s Clinic
By Shachar Tauber, M.D.
During
the past three years St. John's Clinic-Eye Specialists have been actively
engaged in research as it pertains to helping our patients today and in
the future.
With the strong support
of St. John's Clinic, St. John's Health System and St. John's Foundation
for Community Health, eye research has been successfully undertaken in
both the laboratory and clinical arenas.
To date, 30 clinical
studies have either been completed or continue to actively enroll and
analyze a wide variety of clinical questions.
Our studies include new
treatment options for macular degeneration, diabetic retinopathy,
nasolacrimal duct obstruction, amblyopia therapy, glaucoma compliance,
cataract surgery techniques as well as improving outcomes in LASIK and
lens surgery.
Our confocal microscope,
a generous gift from St. John's Foundation, allows us to see in real time
all the layers of the cornea. This device, the only one in the region, has
allowed us to participate in clinical research studies that would
otherwise be closed to our group.
Our other research arm
involves a first for St. John's. Together with Missouri State University
and the Center for Applied Sciences in Jordan Valley Innovation Center, we
have two major basic science or “bench research“ projects presently
active.
Wendell Scott, M.D., with a grant
from the St. John's Foundation for Research, is investigating the
properties of a commonly used antiseptic for eye surgery. His studies are
looking at the pharmacodynamics and pharmacokinetics of povidone iodine.
Once this is developed, an animal eye model will be constructed. It is
thought that with the proper concentration and drug delivery, this
compound, presently reserved for the use immediately prior to surgery,
may indeed be utilized as an effective and inexpensive treatment to treat
the many causes of ocular infections that are responsible for many cases
of blindness worldwide.
Shachar Tauber, M.D., is leading a
group of investigators from MSU and Case Western Reserve University in the
development of electrospun nanoparticles of type one collagen for the
replacement of corneal stroma lost from infection, inflammation, trauma
or inherited diseases. Further investigation in nanatechnology have
centered in the electrospinning of polymers to improve contact lens fit,
quality and comfort.
Finally, designs using
polymer chemistry are being investigated to enhance drug delivery into the
eye.
While patient care and
satisfaction remains paramount for St. John’s Clinic-Eye Specialists, the
development of research has and continues to provide professional
satisfaction and excitement. We look forward to the contributions of our
colleagues to the world of eye care.
|